Prelude Therapeutics (PRLD) announced the appointment of Katina Dorton to its Board of Directors. Dorton was most recently CFO at NodThera. Dorton will succeed Mardi Dier, who will be resigning from the Prelude board effective October 17. Ms. Dorton will also succeed Ms. Dier as Audit Committee Chair at that time. Ms. Dier has served on Prelude’s board since August 2020.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRLD: